PharmaCyte Biotech’s $15 Million Follow-On Public Offering

Martina Bellini North America, North America Legal Chronicle
Tagged:

Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech, Inc. on the deal.PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here